Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tissue Regenix Group (TRX) Share Price

Price 36.50p on 15-04-2025 at 05:00:06
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Buy / Sell TRX Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 2.00 at 37.00p
Day's Volume: 0
Last Close: 36.50p
Open: 0.00p
ISIN: GB00BNTXR104
Day's Range 0.00p - 0.00p
52wk Range: 34.50p - 74.00p
Market Capitalisation: £26m
VWAP: 0.00p
Shares in Issue: 71m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Tissue Regenix Group (TRX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 2 37.00p SI Trade
 14:33:05 - 14-Apr-25
Buy* 3 37.00p SI Trade
 14:33:05 - 14-Apr-25
Buy* 9,958 37.56p Ordinary
 11:45:42 - 14-Apr-25
Buy* 2,000 37.60p Ordinary
 11:33:13 - 14-Apr-25
Sell* 195 36.00p Ordinary
 10:16:52 - 14-Apr-25
Buy* 88 37.80p Ordinary
 09:45:37 - 14-Apr-25
Buy* 18 38.00p SI Trade
 09:16:59 - 14-Apr-25
Buy* 85 39.00p SI Trade
 09:16:58 - 14-Apr-25
Buy* 2 39.00p SI Trade
 09:16:58 - 14-Apr-25
Sell* 552 36.00p SI Trade
 09:16:58 - 14-Apr-25
See more Tissue Regenix Group trades

Tissue Regenix Group (TRX) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Apr 2025 (Mon) 37.50 37.50 36.50 36.50 22,903
11th Apr 2025 (Fri) 38.00 38.00 37.50 37.50 14,807
10th Apr 2025 (Thu) 38.00 38.00 38.00 38.00 10,591
9th Apr 2025 (Wed) 38.00 38.00 38.00 38.00 137,636
8th Apr 2025 (Tue) 35.00 38.00 35.00 38.00 203,201
7th Apr 2025 (Mon) 36.00 36.00 34.50 34.50 23,283
4th Apr 2025 (Fri) 36.50 36.50 36.00 36.00 32,656
3rd Apr 2025 (Thu) 37.00 37.00 36.50 36.50 1,683
2nd Apr 2025 (Wed) 37.00 37.00 37.00 37.00 2,389
1st Apr 2025 (Tue) 37.00 37.00 37.00 37.00 3,626
31st Mar 2025 (Mon) 36.75 38.00 38.00 38.00 46,353
28th Mar 2025 (Fri) 36.00 36.75 36.00 36.75 37,658
27th Mar 2025 (Thu) 36.00 36.00 36.00 36.00 21,034
26th Mar 2025 (Wed) 36.00 36.00 36.00 36.00 11,849
25th Mar 2025 (Tue) 36.00 36.00 35.30 36.00 23,236
24th Mar 2025 (Mon) 36.50 36.50 36.50 36.50 8,644
21st Mar 2025 (Fri) 37.00 37.00 36.50 36.50 56,217
20th Mar 2025 (Thu) 38.00 38.00 37.00 37.00 127,377
19th Mar 2025 (Wed) 40.50 41.80 38.00 38.00 25,773
18th Mar 2025 (Tue) 40.50 40.50 40.50 40.50 71,005
17th Mar 2025 (Mon) 40.50 43.40 40.50 40.50 31,789
See more Tissue Regenix Group price history

Tissue Regenix Group (TRX) Regulatory News

Date Source Headline
10th Apr 2025 9:09 am RNS Form 8.5 (EPT/NON-RI)
9th Apr 2025 10:45 am RNS Form 8.5 (EPT/NON-RI)
8th Apr 2025 7:00 am RNS Conclusion of Strategic Review & Offer Period
7th Apr 2025 8:46 am RNS Form 8.5 (EPT/NON-RI)
1st Apr 2025 9:12 am RNS Form 8.5 (EPT/NON-RI)
31st Mar 2025 9:21 am RNS Form 8.5 (EPT/NON-RI)
27th Mar 2025 7:00 am RNS European patent granted
25th Mar 2025 8:58 am RNS Form 8.5- Tissue Regenix Group Plc
21st Mar 2025 8:36 am RNS Form 8.5 (EPT/NON-RI)
20th Mar 2025 9:19 am RNS Form 8.5 (EPT/NON-RI)
See more Tissue Regenix Group regulatory news

Tissue Regenix Group (TRX) Share News

IN BRIEF: Tissue Regenix granted European patent for dCELL

27th Mar 2025 20:17

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Says European Patent Office grants European patent (EP4114476) for its decellularisation technology, dCELL. The patent relates to the method for producing decellularisation tissue scaffold which is a foundation for Tissue Regenix's platform and plays a pivotal role in the development of its product range. This patent adds to those the company already has granted in the US and UK for dCELL. Read More

IN BRIEF: Tissue Regenix eyes profit beat; plots German jv disposal

31st Jan 2025 21:30

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Revenue increases 8% to USD28.4 million in the year ending December 31 from USD26.3 million a year prior. In addition, expects to report an adjusted earnings before interest, tax, depreciation and amortisation above expectations. Notes this will mark the second full year of profitability for Tissue Regenix and the fourth year of above-market growth. Read More

IN BRIEF: Tissue Regenix contacts firms as it considers possible sale

4th Nov 2024 18:21

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - In response to press reports, say that it is conducting a review of strategic options, which may include soliciting offers for Tissue Regenix. Accordingly, the firm has contacted a limited number of potential counterparties to assess whether they could put forward a proposal "that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy". Says it has not received any indicative non-binding proposals to date, and says there can be no certainty any offer will be made. Read More

EARNINGS AND TRADING: Blackbird loss narrows; Futura Medical in profit

10th Sep 2024 21:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

3rd Sep 2024 11:31

Read More

See more Tissue Regenix Group news
FTSE 100 Latest
Value8,134.34
Change0.00

Login to your account

Forgot Password?

Not Registered